As described previously, LSD1 is overexpressed in various cancer cells including ER-negative breast cancer, bladder, prostate, lymphoid neoplasm, lung cancer, and acute myeloid leukaemia cells, and is associated with poor prognosis of various tumours. Here, KDM1A is linked to cancer.